245 related articles for article (PubMed ID: 29323104)
1. The mechanism of glycosphingolipid degradation revealed by a GALC-SapA complex structure.
Hill CH; Cook GM; Spratley SJ; Fawke S; Graham SC; Deane JE
Nat Commun; 2018 Jan; 9(1):151. PubMed ID: 29323104
[TBL] [Abstract][Full Text] [Related]
2. Structure of human saposin A at lysosomal pH.
Hill CH; Read RJ; Deane JE
Acta Crystallogr F Struct Biol Commun; 2015 Jul; 71(Pt 7):895-900. PubMed ID: 26144235
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants.
Spratley SJ; Hill CH; Viuff AH; Edgar JR; Skjødt K; Deane JE
Traffic; 2016 Aug; 17(8):908-22. PubMed ID: 27126738
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.
Sun Y; Zamzow M; Ran H; Zhang W; Quinn B; Barnes S; Witte DP; Setchell KD; Williams MT; Vorhees CV; Grabowski GA
Hum Mol Genet; 2013 Jun; 22(12):2435-50. PubMed ID: 23446636
[TBL] [Abstract][Full Text] [Related]
5. Altered autophagy in the mice with a deficiency of saposin A and saposin B.
Sun Y; Grabowski GA
Autophagy; 2013 Jul; 9(7):1115-6. PubMed ID: 23697974
[TBL] [Abstract][Full Text] [Related]
6. Rare Saposin A deficiency: Novel variant and psychosine analysis.
Calderwood L; Wenger DA; Matern D; Dahmoush H; Watiker V; Lee C
Mol Genet Metab; 2020 Feb; 129(2):161-164. PubMed ID: 31439510
[TBL] [Abstract][Full Text] [Related]
7. Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.
Hill CH; Graham SC; Read RJ; Deane JE
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20479-84. PubMed ID: 24297913
[TBL] [Abstract][Full Text] [Related]
8. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
9. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.
Sun Y; Witte DP; Zamzow M; Ran H; Quinn B; Matsuda J; Grabowski GA
Hum Mol Genet; 2007 Apr; 16(8):957-71. PubMed ID: 17353235
[TBL] [Abstract][Full Text] [Related]
10. A convenient oxidation of natural glycosphingolipids to their "ceramide acids" for neoglycoconjugation. Bovine serum albumin-glycosylceramide acid conjugates as investigative probes for HIV gp120 coat protein-glycosphingolipid interactions.
Mylvaganam M; Lingwood CA
J Biol Chem; 1999 Jul; 274(29):20725-32. PubMed ID: 10400707
[TBL] [Abstract][Full Text] [Related]
11. A Tetrameric Assembly of Saposin A: Increasing Structural Diversity in Lipid Transfer Proteins.
Shamin M; Spratley SJ; Graham SC; Deane JE
Contact (Thousand Oaks); 2021 Jan; 4():251525642110523. PubMed ID: 37143956
[TBL] [Abstract][Full Text] [Related]
12. β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism.
Belleri M; Paganini G; Coltrini D; Ronca R; Zizioli D; Corsini M; Barbieri A; Grillo E; Calza S; Bresciani R; Maiorano E; Mastropasqua MG; Annese T; Giacomini A; Ribatti D; Casas J; Levade T; Fabrias G; Presta M
Cancer Res; 2020 Nov; 80(22):5011-5023. PubMed ID: 32998995
[TBL] [Abstract][Full Text] [Related]
13. Azasugar inhibitors as pharmacological chaperones for Krabbe disease.
Hill CH; Viuff AH; Spratley SJ; Salamone S; Christensen SH; Read RJ; Moriarty NW; Jensen HH; Deane JE
Chem Sci; 2015 May; 6(5):3075-3086. PubMed ID: 26029356
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of saposin D in an open conformation.
Gebai A; Gorelik A; Nagar B
J Struct Biol; 2018 Nov; 204(2):145-150. PubMed ID: 30026085
[TBL] [Abstract][Full Text] [Related]
15. Insights into Krabbe disease from structures of galactocerebrosidase.
Deane JE; Graham SC; Kim NN; Stein PE; McNair R; Cachón-González MB; Cox TM; Read RJ
Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15169-73. PubMed ID: 21876145
[TBL] [Abstract][Full Text] [Related]
16. Glycosphingolipid specificity of the human sulfatide activator protein.
Vogel A; Schwarzmann G; Sandhoff K
Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
[TBL] [Abstract][Full Text] [Related]
17. Direct visualization of saposin remodelling of lipid bilayers.
Alattia JR; Shaw JE; Yip CM; Privé GG
J Mol Biol; 2006 Oct; 362(5):943-53. PubMed ID: 16949605
[TBL] [Abstract][Full Text] [Related]
18. Saposins and their interaction with lipids.
Vaccaro AM; Salvioli R; Tatti M; Ciaffoni F
Neurochem Res; 1999 Feb; 24(2):307-14. PubMed ID: 9972880
[TBL] [Abstract][Full Text] [Related]
19. Saposin A: second cerebrosidase activator protein.
Morimoto S; Martin BM; Yamamoto Y; Kretz KA; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1989 May; 86(9):3389-93. PubMed ID: 2717620
[TBL] [Abstract][Full Text] [Related]
20. A Specific Activity-Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease.
Marques AR; Willems LI; Herrera Moro D; Florea BI; Scheij S; Ottenhoff R; van Roomen CP; Verhoek M; Nelson JK; Kallemeijn WW; Biela-Banas A; Martin OR; Cachón-González MB; Kim NN; Cox TM; Boot RG; Overkleeft HS; Aerts JM
Chembiochem; 2017 Feb; 18(4):402-412. PubMed ID: 28000364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
